Enisamium is a small molecule inhibitor of the influenza A virus and SARS-CoV-2 RNA polymerases
A. Walker, H. Fan, J. R. Keown, V. Margitich, J. M. Grimes, E. Fodor, A. J. te Velthuis
This paper shows enisamium and its metabolite VR17-04 inhibit RNA polymerases of influenza A and SARS-CoV-2, with VR17-04 matching remdesivir's efficacy against SARS-CoV-2.
bioRxiv · Apr 21, 2020 · PreprintMicrobiology